Anteris Technologies Global Corp.

Contributing Author

Recent Articles by Anteris Technologies Global Corp.

Jan-20	Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering AVR GlobeNewswire
Jan-20	Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic AVR +12.52% GlobeNewswire
Nov-17	Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves AVR GlobeNewswire
Nov-12	Anteris Announces Results for the Third Quarter of 2025 AVR GlobeNewswire
Nov-03	FDA Approves Anteris's DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") AVR GlobeNewswire
Oct-28	Anteris DurAVR THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year AVR GlobeNewswire
Oct-27	Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") AVR GlobeNewswire
Oct-27	Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR THV to be Presented at TCT 2025 AVR GlobeNewswire
Oct-15	Anteris Receives First European Regulatory Clearance to Commence DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") AVR GlobeNewswire
Sep-19	Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders AVR GlobeNewswire
Sep-11	Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders AVR GlobeNewswire
Sep-04	Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders AVR GlobeNewswire
Aug-11	Anteris Announces Results for the Second Quarter of 2025 AVR GlobeNewswire
Jun-09	Anteris Appoints David Roberts and Gregory Moss to its Board of Directors AVR GlobeNewswire
May-13	Anteris Announces Results for the First Quarter of 2025 AVR GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.